These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5420832)

  • 1. Clinical experiences with Leron (guanacline) in the treatment of hypertension.
    Seedat YK
    S Afr Med J; 1970 May; 44(19):562-3. PubMed ID: 5420832
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the antihypertensive efficacy of guanoxan].
    Ambrosioni E; Magelli C; Magnani B
    G Clin Med; 1977; 58(1-2):19-30. PubMed ID: 143388
    [No Abstract]   [Full Text] [Related]  

  • 3. [First experience in the long term treatment with the antihypertensive Guancydin including studies of the renin-angiotensin system].
    Werning C; Schweikert HU; Stiel D; Vetter W; Siegenthaler W
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1756-61. PubMed ID: 5451983
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of a new antihypertensive combination (cyclazenine + presinol)].
    Ambrosioni E
    G Clin Med; 1967 Nov; 48(11):1149-62. PubMed ID: 5617984
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences on a new derivative of aminoguanidine with hypotensive action].
    Battaglia A; Raineri A
    Clin Ter; 1966 Feb; 36(4):318-23. PubMed ID: 5941235
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of guanabenz on arterial pressure and the renin-aldosterone system in hypertensive patients].
    Rappelli A; Glorioso N; Tedde R; Madeddu P; Dessì Fulgheri P; Campus S
    Boll Soc Ital Cardiol; 1978; 23(1):177-83. PubMed ID: 754771
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine].
    Montagnani M; Bayelli PF; Antonelli A; Barducci O
    Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical study of guanoxan in the treatment of hypertension.
    Krishnankutty PK; Krishnamurthi TN
    Indian Heart J; 1968 Apr; 20(2):165-73. PubMed ID: 4902803
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new drug in the medical treatment of arterial hypertension: cyclazenin].
    Mameli P; Maioli M; Fanzecu P
    Rass Int Clin Ter; 1970 Apr; 50(8):457-64. PubMed ID: 4394494
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
    Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of guanadrel and guanethidine efficacy and side effects.
    Malinow SH
    Clin Ther; 1983; 5(3):284-9. PubMed ID: 6850722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanacline, a new hypotensive drug.
    Le Moine Parker M; Bullen M
    Med J Aust; 1969 Jan; 1(4):159-62. PubMed ID: 5779041
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term clinical experience with guanfacine.
    Fetkovská N; Brimichová G; Sebeková K; Dzúrik R
    Cor Vasa; 1987; 29(4 Suppl 1):23-9. PubMed ID: 3315447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Minimal useful dose of guanfacine in patients with essential hypertension].
    Pérez Olea J; Ortíz N; Soledad Bertoló M; Allel L; Goity C; Quevedo M
    Rev Med Chil; 1985 May; 113(5):420-4. PubMed ID: 3912882
    [No Abstract]   [Full Text] [Related]  

  • 15. [Guanfacine in primary arterial hypertension: a long-term open clinical study].
    Román O; Valenzuela MA; Salazar R
    Rev Med Chil; 1982 Dec; 110(12):1179-84. PubMed ID: 6764015
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical picture and therapy of hypertension].
    Bernsmeier A
    Munch Med Wochenschr; 1967 Sep; 109(36):1837-45. PubMed ID: 5631765
    [No Abstract]   [Full Text] [Related]  

  • 17. [Animal experiment and clinical studies on the action mechanism of the antihypertensive agent guancydine].
    Werning C; Vetter W; Schweikert HU; Armbruster H; Fischer N; Trübestein G; Siegenthaler W
    Verh Dtsch Ges Inn Med; 1971; 77():1004-8. PubMed ID: 5170618
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N; Knaup G
    Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
    [No Abstract]   [Full Text] [Related]  

  • 19. [Estulic in the long-term treatment of hypertension].
    Rhomberg F
    Schweiz Med Wochenschr; 1980 Dec; 110(50):1922-4. PubMed ID: 6782668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
    Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.